Evolution of the Average Target: Actuate Therapeutics, Inc.

Evolution of the Average Target - Actuate Therapeutics, Inc.

Evolution of the Target Price: Actuate Therapeutics, Inc.

Evolution of the Target Price - Actuate Therapeutics, Inc.

Changes in Analyst Recommendations: Actuate Therapeutics, Inc.

5ad039205d8de69.rmEMeTSTHttc8OwSoB2tgEQAF0KEHP_hGmdljnCAVGs.yBNnIE7-f44tupk_7yvmsiJPRC62Zs3UQz8d6SnEMTvMC11NQMEsoxa9qQ~dfc6b1caf8a4b65019cd09c139b0b12e

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+2,163.33%
+35.78%
+28.93%
+10.89%
+8.75%
+14.18%
+37.21%
+37.85%
+32.7%
+4.59%
Average +237.42%
Weighted average by Cap. +23.89%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.5162USD
Average target price
11.68USD
Spread / Average Target
+2,163.33%
High Price Target
15.05USD
Spread / Highest target
+2,815.54%
Low Price Target
8.000USD
Spread / Lowest Target
+1,449.79%

Analyst Consensus Detail

Analyst consensus - Actuate Therapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Actuate Therapeutics, Inc.
  1. Stock Market
  2. Stocks
  3. ACTU Stock
  4. Consensus Actuate Therapeutics, Inc.